InvestorsHub Logo
Followers 66
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: None

Monday, 02/20/2017 11:19:44 AM

Monday, February 20, 2017 11:19:44 AM

Post# of 345786
Todays new science post:

Cancer patients with higher amounts of myeloid-derived suppressor cells (MDSCs) in their spleens are more likely to die, according to researchers at the University of Colorado Denver Anschutz Medical Campus.




https://immuno-oncologynews.com/2017/02/08/nixing-the-cells-that-nix-immune-response-against-cancer/?utm_source=IO+News&utm_campaign=b3110f79df-RSS_WEEKLY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_f04c303b86-b3110f79df-71537565


What reduces those pesky MDSCs again?

Say it together!!!!

THE APP!!!!! Anti Phosphatidylserine Platform


wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News